About: KannaLife     Goto   Sponge   Distinct   Permalink

An Entity of Type : yago:WikicatPharmaceuticalCompaniesOfTheUnitedStates, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FKannaLife

Kannalife Sciences Inc. , a subsidiary of Neuropathix, Inc., is a bio-pharmaceutical and phyto-medical company based in Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis. Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. Kannalife was featured in Sports Illustrated article on using cannabinoids to treat Concussions and CTE.

AttributesValues
rdf:type
rdfs:label
  • KannaLife (en)
rdfs:comment
  • Kannalife Sciences Inc. , a subsidiary of Neuropathix, Inc., is a bio-pharmaceutical and phyto-medical company based in Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis. Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. Kannalife was featured in Sports Illustrated article on using cannabinoids to treat Concussions and CTE. (en)
foaf:name
  • Kannalife Sciences Inc. (en)
foaf:homepage
name
  • Kannalife Sciences Inc. (en)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/Kannalife-logo.jpg
location
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
thumbnail
assets
  • Exclusive License of patent (en)
foundation
founders
  • Dean Petkanas, Thoma Kikis (en)
homepage
industry
location
logo
type
  • Private (en)
has abstract
  • Kannalife Sciences Inc. , a subsidiary of Neuropathix, Inc., is a bio-pharmaceutical and phyto-medical company based in Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis. Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. In 2011, the company was granted an Exclusive License by National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the Commercialization of patent US 6630507, “Cannabinoids as Antioxidants and Neuroprotectants." Kannalife is currently conducting research and development at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA, for a target drug candidate, KLS-13019 to treat Chemotherapy-induced peripheral neuropathy, Hepatic encephalopathy, Mild Traumatic Brain Injury and CTE, an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain. Kannalife was featured in Sports Illustrated article on using cannabinoids to treat Concussions and CTE. (en)
prov:wasDerivedFrom
page length (characters) of wiki page
founding year
founded by
industry
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is Wikipage redirect of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (61 GB total memory, 49 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software